Active ingredientElobixibatCat. No. P-E025-001CAS 439087-18-0Family · Pharmaceutical analytical standards
Elobixibat
An ileal bile acid transporter (IBAT) inhibitor, approved in Japan in 2018 for chronic constipation: it was the first drug of this class approved anywhere in the world. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?It stops the last part of the small intestine from reabsorbing bile acids, so more of them reach the colon, where they draw in water and stimulate bowel movements.
Go to the active ingredient →Active ingredientElobixibatCat. No. P-E025-001CAS 439087-18-0
Isotopically labelledElobixibat-d5Cat. No. P-E025-002
ImpurityElobixibat Acid ImpurityCat. No. P-E025-004CAS 439086-76-7
ImpurityElobixibat Impurity 1Cat. No. P-E025-005
ImpurityElobixibat Impurity 2Cat. No. P-E025-006
ImpurityElobixibat Impurity 3Cat. No. P-E025-007
ImpurityElobixibat Impurity 4Cat. No. P-E025-008CAS 439088-16-1
ImpurityElobixibat Impurity 5Cat. No. P-E025-009CAS 439088-19-4
ImpurityElobixibat Impurity 6Cat. No. P-E025-010CAS 439087-68-0No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.